Biophysical Characterization Of A Therapeutic mAb And Its Associated Antigen-Binding Fragments

Source: Catalent
Monoclonal antibody MAB GettyImages-1294461540

Changes during purification, formulation, fill-finish, and distribution can affect protein stability and practically all steps in the manufacturing process may perturb the higher-order structure and heterogeneity of the molecule, thus determining size homogeneity of a monoclonal antibody in solution is important for comparability and characterization of these medications. For this study, an IgG antibody was cleaved into antigen-binding fragments using pepsin and papain digestion, followed by protein purification. The fragments, along with intact mAb, were studied by Sedimentation Velocity-Analytical Ultracentrifugation (SV-AUC) and Size-Exclusion Chromatography Multi-Angle Light Scattering (SEC-MALS) to determine sedimentation coefficient, distribution, and molecular weight of each.

Download the poster to learn more about the results from the study and characterization of size and distribution of the intact mAb and enzymatic fragments.

Key Learning

  • The efficacy of orthogonal approaches, SV-AUC and SEC-MALS
  • Effective characterization of intact antibodies, as well as antibody fragments
  • Overlapping and complementary results provide ideal context for further aggregation studies
access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online